Figure 3
From: Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India

(a) 7 days moving average of new cases detected in three cities and point of seroprevalence. (b) Cumulative cases detected in the three cities and point of seroprevalence estimates.